1. Voog U, Alstergren P, Leibur E, Kallikorm R, Kopp S. Impact of temporomandibular joint pain on activities of daily living in patients with rheumatoid arthritis. Acta Odontol Scand. 2003;61(5):278–82.
2. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095–147.
3. Dinarello CA. IL-1, IL-1beta, IL-1 receptor type I, IL-1 receptor type II. In: Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola NA, editors. Cytokine reference. Burlington: Academic; 2000.
4. Koenders MI, Joosten LA, van den Berg WB. Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Ann Rheum Dis. 2006;65 Suppl 3:29–33.
5. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289–96.